Citations (4)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Weichang Luo, Peter D. Arkwright & Ray Borrow. (2020) Antibody persistence following meningococcal ACWY conjugate vaccine licensed in the European Union by age group and vaccine. Expert Review of Vaccines 19:8, pages 745-754.
Read now
Read now
Beatriz Quiambao, Paula Peyrani, Ping Li, Mark W. Cutler, Marie Van Der Wielen, John L. Perez & Chris Webber. (2020) Efficacy and safety of a booster dose of the meningococcal A, C, W, Y-tetanus toxoid conjugate vaccine administered 10 years after primary vaccination and long-term persistence of tetanus toxoid conjugate or polysaccharide vaccine. Human Vaccines & Immunotherapeutics 16:6, pages 1272-1279.
Read now
Read now
Beatriz P. Quiambao, Ashish Bavdekar, Anand Prakash Dubey, Hemant Jain, Devayani Kolhe, Véronique Bianco, Jacqueline M. Miller & Marie Van der Wielen. (2017) Antibody persistence up to 5 y after vaccination with a quadrivalent meningococcal ACWY-tetanus toxoid conjugate vaccine in adolescents. Human Vaccines & Immunotherapeutics 13:3, pages 636-644.
Read now
Read now
Articles from other publishers (1)
Jamie Findlow & Markus Knuf. (2019) Immunogenicity and safety of meningococcal group A, C, W and Y tetanus toxoid conjugate vaccine: review of clinical and real-world evidence. Future Microbiology 14:7, pages 563-580.
Crossref
Crossref